Autori: Davies Andrew
| Naslov | Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial (Article) |
| Autori | Davies Andrew Merli Francesco Mihaljevic Biljana S Mercadal Santiago Siritanaratkul Noppadol Solal-Celigny Philippe Boehnke Axel Berge Claude Genevray Magali Zharkov Artem Dixon Mark Brewster Michael Barrett Martin MacDonald David |
| Info | LANCET HAEMATOLOGY, (2017), vol. 4 br. 6, str. E272-E282 |
| Projekat | F Hoffmann-La Roche |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study (Article) |
| Autori | Davies Andrew Merli Francesco Mihaljevic Biljana S Siritanaratkul Noppadol Solal-Celigny Phillippe Barrett Martin Berge Claude Bittner Beate Boehnke Axel McIntyre Christine MacDonald David |
| Info | LANCET ONCOLOGY, (2014), vol. 15 br. 3, str. 343-352 |
| Projekat | F Hoffmann-La Roche |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa Citati: ISI/Web of Science Scopus |
| Naslov | Subcutaneous Rituximab and Chemotherapy Achieves Similar Trough Levels, Safety, and Response as Intravenous Rituximab in First-Line Follicular Lymphoma: Stage 1 Results of the Phase 3 Sabrina Study (Meeting Abstract) |
| Autori | Davies Andrew Merli Francesco Mihaljevic Biljana S Siritanaratkul Noppadol Solal-Celigny Philippe Boehnke Axel Berge Claude McIntyre Christine Barrett Martin Macdonald David |
| Info | HAEMATOLOGICA, (2013), vol. 98 br. , Suppl. 1, str. 131-132 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
